<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of microbiology, epidemiology and immunobiology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of microbiology, epidemiology and immunobiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Журнал микробиологии, эпидемиологии и иммунобиологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0372-9311</issn><issn publication-format="electronic">2686-7613</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13870</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">FEATURES OF POPULATION COMPOSITION OF PERIPHERAL BLOOD CXCR3-POSITIVE LYMPHOCYTES IN CHRONIC VIRAL HEPATITIS C PATIENTS</article-title><trans-title-group xml:lang="ru"><trans-title>ОСОБЕННОСТИ ПОПУЛЯЦИОННОГО СОСТАВА CXCRS-ПОЛОЖИТЕЛЬНЫХ ЛИМФОЦИТОВ ПЕРИФЕРИЧЕСКОЙ КРОВИ БОЛЬНЫХ ХРОНИЧЕСКИМ ВИРУСНЫМ ГЕПАТИТОМ С</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Semenov</surname><given-names>A. V</given-names></name><name xml:lang="ru"><surname>Семенов</surname><given-names>А. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Arsentieva</surname><given-names>N. A</given-names></name><name xml:lang="ru"><surname>Арсентьева</surname><given-names>Н. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Elezov</surname><given-names>D. S</given-names></name><name xml:lang="ru"><surname>Елезов</surname><given-names>Д. С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudryavtsev</surname><given-names>I. V</given-names></name><name xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Esaulenko</surname><given-names>E. V</given-names></name><name xml:lang="ru"><surname>Эсауленко</surname><given-names>Е. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Totolyan</surname><given-names>A. A</given-names></name><name xml:lang="ru"><surname>Тотолян</surname><given-names>А. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pasteur Research Institute of Epidemiology and Microbiology, St. Petersburg, Russia</institution></aff><aff><institution xml:lang="ru">НИИ эпидемиологии и микробиологии им. Пастера, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Institute of Experimental Medicine, St. Petersburg, Russia</institution></aff><aff><institution xml:lang="ru">НИИ экспериментальной медицины, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">State Pediatric Medical University, St. Petersburg, Russia</institution></aff><aff><institution xml:lang="ru">Государственный педиатрический медицинский университет, Санкт-Петербург</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2013</year></pub-date><volume>90</volume><issue>6</issue><issue-title xml:lang="en">NO6 (2013)</issue-title><issue-title xml:lang="ru">№6 (2013)</issue-title><fpage>69</fpage><lpage>76</lpage><history><date date-type="received" iso-8601-date="2023-06-09"><day>09</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Semenov A.V., Arsentieva N.A., Elezov D.S., Kudryavtsev I.V., Esaulenko E.V., Totolyan A.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, Семенов А.В., Арсентьева Н.А., Елезов Д.С., Кудрявцев И.В., Эсауленко Е.В., Тотолян А.А.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Semenov A.V., Arsentieva N.A., Elezov D.S., Kudryavtsev I.V., Esaulenko E.V., Totolyan A.A.</copyright-holder><copyright-holder xml:lang="ru">Семенов А.В., Арсентьева Н.А., Елезов Д.С., Кудрявцев И.В., Эсауленко Е.В., Тотолян А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://microbiol.crie.ru/jour/article/view/13870">https://microbiol.crie.ru/jour/article/view/13870</self-uri><abstract xml:lang="en"><p>Aim. Quantitative determination of CXCR3+, CCR5+ and CCR6+ cells in major lymphocyte populations: T-helpers (Th), cytotoxic T-lymphocytes (CTL), natural killers (NK) and T-natural killer cells (TNK), B-lymphocytes in patients with chronic viral hepatitis C (CVHC). Materials and methods. Content of lymphocyte populations carrying chemokine receptor CXCR3 was studied, chemokine receptors CCR5 and CCR6 were evaluated on T-lymphocytes, in peripheral blood of 19 CVHC patients and 32 conditionally healthy donors. Cell populations were determined by flow cytofluorometry by using various combinations of monoclonal antibodies: for evaluation of Th and CTL (CD3/CD4/CD8/CXCR3/CCR5/CCR6); NK and TNK (CD16/CD56/CD3/ CXCR3); B-cells (CD19/CD45/CXCR3). Results. In patients with CVHV compared with healthy donors a significant increase of quantity of CXCR3-positive Th was detected, however the content of CXCR3-positive CTL did not differ in the groups compared; CXCR3+ NK cell content was lower with equal content of CXCR3+ TNK. Analysis of quantity of CXCR3+ B-cells showed an increase of more than 3.5 times in CVHC patients. Significant differences in relative content of Th and CTL carrying CCR5 and CCR6 were not detected despite a non-significant increase of quantity of CCR5+ and CCR6+ Th. Conclusion. Content of major lymphocyte populations carrying chemokine receptor CXCR3 changed significantly compared with conditionally healthy donors in peripheral blood of CVHC patients. The increase of quantity of CXCR3-positive B-cells may be associated with infection of these cells by HCV or development of extra-liver manifestations of HVHC.</p></abstract><trans-abstract xml:lang="ru"><p>Цель. Количественное определение CXCR3+, CCR5+ и CCR6+ клеток в основных популяциях лимфоцитов: Т-хелперах (Th), цитотоксических Т-лимфоцитах (CTL), натуральных киллерных (NK) и Т-натуральных киллерных клетках (TNK), В-лимфоцитах у больных хроническим вирусным гепатитом С (ХВГС). Материалы и методы. Исследовали содержание популяций лимфоцитов, несущих хемокиновый рецептор CXCR3, на Т-лимфоцитах оценивали хемокиновые рецепторы CCR5 и CCR6 в периферической крови 19 больных ХВГС и 32 условно здоровых доноров. Популяции клеток определяли методом проточной цитофлюориметрии с использованием различных комбинаций моноклональных антител: для оценки Th и CTL (CD3/CD4/CD8/CXCR3/CCR5/CCR6); NK и TNK (CD16/CD56/CD3/CXCR3); В-клеток (CD19/CD45/CXCR3). Результаты. У пациентов с ХВГС, по сравнению со здоровыми донорами, обнаружено значительное возрастание количества CXCR3-положительных Th, хотя содержание CXCR3-положительных CTL не отличалось в сравниваемых группах; снижено содержание CXCR3+ NK клеток при одинаковом содержании CXCR3+ TNK. Анализ количества CXCR3+ В-клеток показал увеличение их более чем в 3,5 раза у больных ХВГС. Не выявлено достоверных различий в относительном содержании Th и CTL, несущих CCR5 и CCR6, несмотря на незначительное возрастание количества CCR5+ и CCR6+ Th. Заключение. В периферической крови больных ХВГС значительно изменялось содержание основных популяций лимфоцитов, несущих хемокиновый рецептор CXCR3, по сравнению с условно здоровыми донорами. Увеличение количества CXCR3-положительных В-клеток может быть связано с инфицированием этих клеток ВГС и развитием внепеченочных проявлений ХВГС.</p></trans-abstract><kwd-group xml:lang="en"><kwd>CXCR3</kwd><kwd>CCR5</kwd><kwd>CCR6</kwd><kwd>hepatitis C</kwd><kwd>chemokine receptors</kwd><kwd>flow cytometry</kwd><kwd>CXCR3</kwd><kwd>CCR5</kwd><kwd>CCR6</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гепатит С</kwd><kwd>рецепторы хемокинов</kwd><kwd>проточная цитометрия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Арсентьева Н.А., Семенов А.В., Тотолян Арег А. Роль полиморфизма генов цитокинов при вирусном гепатите С. Инфекция и иммунитет. 2012, 2 (4): 687-698.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Жданов К.В., Гусев Д.А., Чирский В.С. и др. Экспрессия хемокинов и их рецепторов в крови и ткани печени при хроническом вирусном гепатите С. Мед. иммунология. 2007, 9 (4-5): 379-388.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Михайлов М.И. Вирусы гепатита. Клиническая гепатология. 2009, 1: 15-24.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Семенов А.В., Вашукова С.С., Рахманова А.Г. Предварительные итоги лабораторной диагностики вирусных гепатитов В и С в рамках приоритетной национальной программы «Здоровье» в Санкт-Петербурге. Медико-биологические и социально-психологические проблемы безопасности в чрезвычайных ситуациях. 2010, 3: 61-64.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ahmad A., Alvarez A. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J. Leukoc. Biol. 2004, 76 (4): 743-759.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Apolinario A., Diago M., Lo Iacono O. et al. Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginter-feron plus ribavirin combination therapy. Aliment. Pharmacol. Ther. 2004, 19: 551-562.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bertoletti A., Maini M.K. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr. Opin. Immunol. 2000, 12: 403-408.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Casrouge A., DecalfJ., Ahloulay M. et al. Evidence for an antagonist form ofthe chemokine CXCL10 in patients chronically infected with HCV J. Clin. Invest. 2011, 121 (1): 308-317.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Khakoo S.I., Thio C.L., Martin M.P. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004, 305: 872-874.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Larrubia J.R., Benito-Martinez S., Calvino M. et al. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J. Gastroenterol. 2008, 14: 7149-7159.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Mizuochi T., Ito M., Saito K., Kasai M. et al. Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B cells to the liver of chronic hepatitis C patients. J. Interf. Cytok. Res. 2010, 30 (4): 243-251.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Oo YH., Shetty S., Adams D.H. The role of chemokines in the recruitment of lymphocytes to the liver. Immunol. Liver Dis. 2010, 28: 31-44.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Penna A., Pilli M., Zerbini A. Molecular basis for the defective cytotoxic response in chronic HCV infection. J. Hepatol. 2005, 42 (2): 164-165.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Shimizu Y, Murata H., Kashii Y. et al. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3 might be involved in the amplification of local necroinflammatory response in the liver. Hepatology. 2001, 34 (2): 311-319.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Sun J.C., Beilke J.N., Lanier L. Adaptive immune features of natural killer cells. Nature (Cr. Brit.). 2009, 457 (7229): 557-561.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Wozniakowska-Gesicka T. Winiewska-Ligier M., Kaluzynski A. Intrahepatic and peripheral blood NK cells in patients with chronic hepatitis C. Med. Wieku. Rozwoj. 2002, 6 (3): 203-211.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Zeremski M., Petrovic L.M., Chiriboga L. et al. Intrahepatic levels of CXCR3-associated chemok-ines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology. 2008, 48 (5): 1440-50.</mixed-citation></ref></ref-list></back></article>
